Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial-Reference-Cited by-同舟云学术

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Published:2012-12 Issue:12 Volume:13 Page:1225-1233
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

de Gramont Aimery,Van Cutsem Eric,Schmoll Hans-Joachim,Tabernero Josep,Clarke Stephen,Moore Malcolm J,Cunningham David,Cartwright Thomas H,Hecht J Randolph,Rivera Fernando,Im Seock-Ah,Bodoky György,Salazar Ramon,Maindrault-Goebel Frédérique,Shacham-Shmueli Einat,Bajetta Emilio,Makrutzki Martina,Shang Aijing,André Thierry,Hoff Paulo M

Publisher

Elsevier BV

Subject

Oncology

Reference37 articles.

1. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials;Sargent;J Clin Oncol,2009

2. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1;André;J Clin Oncol,2007

3. Capecitabine as adjuvant treatment for stage III colon cancer;Twelves;N Engl J Med,2005

4. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004

5. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

Cited by 473 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial;Journal of Clinical Oncology;2024-09-01

2. Curative Surgery After Neoadjuvant Chemotherapy for Locally Advanced Sigmoid Colon Cancer With Extensive Abdominal Wall Invasion: A Case Report;Cureus;2024-08-21

3. Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study);Journal of the Anus, Rectum and Colon;2024-07-25

4. Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions;Discover Oncology;2024-07-20

5. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?;Cancers;2024-05-31